On March 17 this year, a man was taken to hospital in Israel suffering from a dry cough and a loss of sense of smell. He developed a fever and felt tired but, after three days as an in-patient, was released to quarantine. Then something strange started happening.
His handwriting changed. It became smaller, crabbed and unreadable. Not just that, but he struggled to speak clearly or write texts on his phone. His right hand began to tremble. Eventually, symptoms became so bad that he returned to hospital, this time to the department of neurology, dealing in disorders of the brain and nervous system. A battery of tests was performed. Then doctors gave him a devastating diagnosis: Parkinson’s. The man was just 45. It was two months since his positive test for Covid-19.
This case, newly described, is not unique. Across the world, doctors have noticed that Covid is often accompanied not just by the familiar shortness of breath and coughing that affect the body, but also by a huge range of conditions hitting the brain – from foggy thinking, through delirium, all the way to strokes and Parkinsonism.
So serious was this in Britain that, as the pandemic took hold early this year, doctors set up a monthly committee to coordinate reports of brain disorders. Neurologist Dr Hadi Manji was among them. Very quickly, he says: “We had to make the meeting weekly because of the numbers of referrals.”
Indeed, new research from Chicago reports that one third of Covid patients hospitalised early in the pandemic suffered some form of altered mental state – from confusion to unresponsiveness. That in itself is not so unusual. Being seriously ill affects lucidity. According to Mary Ni Lochlainn, fellow in Geriatric Medicine at King’s College London, up to 80 per cent of those in intensive care suffer delirium. But the consequences with Covid, the Chicago statistics suggest, are dramatic. Those with brain disorders needed three times as long in hospital as those without and were seven times more likely to die. On discharge only a third could perform routine tasks.
Image Credit: iMrSquid
SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos [...]
ANSTO has contributed to a comprehensive investigation of a promising type of nanoparticle that could potentially be used for intractable brain cancers in a combined therapy. The study, which was led by Dr. Moeava [...]
The immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed. Human challenge trials involve deliberately exposing healthy people to a [...]
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
The coronavirus outbreak made household names of companies like Moderna Inc. and BioNTech SE, whose shots offered hope for ending the pandemic. Now a new wave of vaccines is on the horizon that may get the [...]
Researchers at the University of Southampton have developed a new way of using nanomaterials to identify and enrich skeletal stem cells—a discovery which could eventually lead to new treatments for major bone fractures and [...]
In March 2020, Hannu Rajaniemi pivoted his biotech company Helix Nanotechnologies' focus from cancer therapies to Covid-19 vaccines. The role biotech start-ups can play in a pandemic Rajaniemi originally co-founded Helix Nanotechnologies in Cambridge, Massachusetts in [...]
The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts. That is the small price of the [...]
Covid-19 vaccines are incredibly good at preventing severe symptoms and hospitalization, but they’re probably less effective at stopping transmission. To do that, we might need a different kind of vaccine altogether. Because SARS-CoV-2 is [...]